Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 3/20 | 0.37 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.36 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | MPL | P40238 | 1/20 | 0.32 |
| ▸ | KMO | O15229 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20411757 | 0.85 | ALPL (0.38) | ALPLABCC8KCNJ11ALOX5APCYP1A2 | |
| SCHEMBL20414974 | 0.82 | ABCC8 (0.35) | ALPLABCC8KCNJ11 | |
| SCHEMBL19612560 | 0.80 | ALPL (0.40) | ALPLABCC8KCNJ11ALOX5APCYP1A2 | |
| SCHEMBL12626950 | 0.78 | ALPL (0.35) | ALPLABCC8KCNJ11KMO | |
| SCHEMBL17077595 | 0.76 | NPC1 (0.45) | ALPLTGFBR1KMO | |
| SCHEMBL27931261 | 0.76 | NPC1 (0.45) | ALPLTGFBR1KMO | |
| SCHEMBL17077592 | 0.75 | NPC1 (0.44) | ALPLALOX5APTGFBR1 | |
| SCHEMBL28864794 | 0.75 | NPC1 (0.44) | ALPLTGFBR1KMO | |
| SCHEMBL27910618 | 0.75 | NPC1 (0.44) | ALPLTGFBR1KMO | |
| SCHEMBL20414973 | 0.75 | POLB (0.41) | TNKSPARP1TNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10396298-B2 | Iridium complex and organic light-emitting diode using the same | NATIONAL TSING HUA UNIVERSITY (TW) | 2019-08-27 | — | — | US | disclosed |
| US-20180212161-A1 | IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DIODE USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2018-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180212161-A1 | IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DIODE USING THE SAME | OCIAD1, OGFOD1, OGDH | ALPL 2444/4885ABCC8 3319/4885KCNJ11 3533/4885 |
| US-10396298-B2 | Iridium complex and organic light-emitting diode using the same | OCIAD1, OGFOD1, OGDH | ALPL 2444/4885ABCC8 3319/4885KCNJ11 3533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.